Anupam Verma, MD
Fellowship: Pediatric Hematology Oncology, University of Utah, Salt Lake City, UT (2012)
Chief Resident: Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, NY (2005)
Residency: Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, NY (2005)
Residency: Pediatrics, All India Institute of Medical Science, New Delhi, India (2002)
Residency: Pediatrics, M S University of Baroda Medical College, India (2000)
Medical School: M S University of Baroda Medical College, India (1996)
Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome (ML-DS). Blood Adv. 2023 Feb. PMID: 36735769
Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia. 2023 May. PMID: 36813993
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Infect Control Hosp Epidemiol. 2022. PMID: 35465865
Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia. Blood Lymphat Cancer, 2021. P MCID: PMC8064615
PEGylated E. Coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi Availability. Pediatr Hematol Oncol, 2019.
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management after Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Network Open, 2021.
Kids-DOTT Trial Investigators and the ATLAS Group. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022. PMID: 35015038